PubMed COVID-19 Clinical Care

The pathobiology of respiratory failure in COVID-19 consists of a complex interplay between viral cytopathic effects and a dysregulated host immune response. In critically ill patients, imatinib treatment demonstrated potential for reducing invasive

CONCLUSION: These results indicate that SARS-CoV-2 may prime the patient for subsequent development of liver infections or non-infectious liver diseases. While rare (~1 in 1000), SARS-CoV-2 is a risk for subsequent abnormalities in liver function or

Not available.

CONCLUSION: Our results indicate that mild COVID-19 infection affects lung function at time of infection with limited recovery two years after infection.

Lentiviral-mediated transfection technique is a powerful tool for gene modification in preclinical studies. By using this technique, the desired gene modification can be achieved easily in immune cells, nondividing, and terminally differentiated

PURPOSE: Treatments for myalgic encephalomyelitis and chronic fatigue syndrome can be adapted for post-COVID-19 condition. Our aim was to compare treatments in patients from our post-COVID-19 clinic.

The COVID-19 pandemic was an unexpected event with far-reaching long-term economic, political, and social consequences, entailing disruptive changes with potentially existence- and livelihood threatening consequences. Lessons in resilience from

This manuscript is being submitted as a Commentary; Abstract not applicable.

CONCLUSION: As COVID-19 restrictions lessened, there were more opportunities for children to reduce SB, but there were still barriers to engage in PA.

No abstract